$27.68
0.80%
Nasdaq, Aug 29, 10:00 pm CET
ISIN
US53635D2027
Symbol
LQDA

Liquidia Technologies, Inc. Stock price

$27.68
+8.42 43.72% 1M
+12.19 78.70% 6M
+15.92 135.37% YTD
+18.14 190.15% 1Y
+19.95 258.09% 3Y
+22.56 440.63% 5Y
+16.58 149.37% 10Y
+16.58 149.37% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
+0.22 0.80%
ISIN
US53635D2027
Symbol
LQDA
Industry

Key metrics

Basic
Market capitalization
$2.4b
Enterprise Value
$2.4b
Net debt
$20.2m
Cash
$173.4m
Shares outstanding
85.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
123.3 | 36.8
EV/Sales
124.4 | 37.1
EV/FCF
negative
P/B
156.9
Financial Health
Equity Ratio
33.5%
Return on Equity
-169.3%
ROCE
-73.2%
ROIC
-
Debt/Equity
12.7
Financials (TTM | estimate)
Revenue
$19.3m | $64.7m
EBITDA
$-129.2m | $-124.8m
EBIT
$-131.0m | $-130.0m
Net Income
$-141.5m | $-139.3m
Free Cash Flow
$-124.0m
Growth (TTM | estimate)
Revenue
30.2% | 362.2%
EBITDA
-32.8% | -3.0%
EBIT
-34.6% | -7.2%
Net Income
-26.2% | -6.8%
Free Cash Flow
-41.4%
Margin (TTM | estimate)
Gross
69.3%
EBITDA
-668.4% | -192.9%
EBIT
-678.0%
Net
-732.2% | -215.3%
Free Cash Flow
-641.6%
More
EPS
$-1.7
FCF per Share
$-1.4
Short interest
26.6%
Employees
170
Rev per Employee
$80.0k
Show more

Is Liquidia Technologies, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Liquidia Technologies, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Liquidia Technologies, Inc. forecast:

14x Buy
88%
1x Hold
6%
1x Sell
6%

Analyst Opinions

16 Analysts have issued a Liquidia Technologies, Inc. forecast:

Buy
88%
Hold
6%
Sell
6%

Financial data from Liquidia Technologies, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
19 19
30% 30%
100%
- Direct Costs 5.93 5.93
31% 31%
31%
13 13
30% 30%
69%
- Selling and Administrative Expenses 110 110
62% 62%
571%
- Research and Development Expense 41 41
4% 4%
214%
-129 -129
33% 33%
-668%
- Depreciation and Amortization 1.86 1.86
1,967% 1,967%
10%
EBIT (Operating Income) EBIT -131 -131
35% 35%
-678%
Net Profit -141 -141
26% 26%
-732%

In millions USD.

Don't miss a Thing! We will send you all news about Liquidia Technologies, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Liquidia Technologies, Inc. Stock News

Neutral
GlobeNewsWire
5 days ago
MORRISVILLE, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that members of the company's executive leadership team will be providing an update on the company's business during a fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, beginning at 3:45 p.m. ET in Boston.
Neutral
Seeking Alpha
20 days ago
Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript
Positive
Investors Business Daily
20 days ago
Liquidia stock shot higher Tuesday after its new drug, Yutrepia, widely beat prescription and patient start expectations.
More Liquidia Technologies, Inc. News

Company Profile

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

Head office United States
CEO Roger Jeffs
Employees 170
Founded 2004
Website www.liquidia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today